Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in multiple myeloma.

R Alexanian, S Balcerzak, J D Bonnet

    Cancer
    |October 1, 1975
    PubMed
    Summary

    Disease severity in multiple myeloma patients significantly impacts survival and remission. Higher levels of anemia, hypercalcemia, and tumor burden correlate with shorter lifespans and remissions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Comment on the contribution by Erna J. Schilder (1988): Restraining patients? A study of the use of restraints in nursing]].

    Pflege·2012
    Same author

    Acromegaly associated with amyotrophic lateral sclerosis and acromegaly of the amyotrophic type.

    Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.)·2010
    Same author

    Acromegaly associated with amyotrophic lateral sclerosis and acromegaly of the amyotrophic type report of three cases.

    The Journal of clinical endocrinology and metabolism·2010
    Same author

    Brucella abortus infection of the gallbladder treated with streptomycin; report of a case.

    Cleveland Clinic quarterly·2010
    Same author

    Succinyl sulfathiazole (sulfasuxidine) in the treatment of chronic ulcerative colitis; a report of 55 cases followed two years; its value by retention enema in early cases.

    Gastroenterology·2010
    Same author

    Asymptomatic Waldenstrom's macroglobulinemia.

    Seminars in oncology·2003

    Area of Science:

    • Oncology
    • Hematology

    Background:

    • Multiple myeloma is a cancer of plasma cells.
    • Treatment outcomes can vary significantly between patients.

    Purpose of the Study:

    • To evaluate the impact of specific multiple myeloma disease parameters on patient survival and remission duration.
    • To assess the relationship between tumor burden and treatment response.

    Main Methods:

    • Retrospective analysis of 482 multiple myeloma patients treated with melphalan-prednisone.
    • Evaluation of disease parameters including anemia, hypercalcemia, azotemia, serum myeloma protein, and tumor mass.
    • Correlation of these parameters with remission and survival times.

    Main Results:

    • Anemia, hypercalcemia, azotemia, and high myeloma protein levels were linked to shorter survival.
    • Advanced myeloma stages correlated with immunoglobulin depression.
    • Increased tumor mass was associated with shorter lifespans, though not response rate.
    • Greater tumor reduction correlated with longer remission and survival, but rapid reduction predicted poorer outcomes.

    Conclusions:

    • Disease parameters like anemia and hypercalcemia are critical prognostic indicators in multiple myeloma.
    • Tumor burden and the rate of tumor reduction influence survival and remission.
    • Optimizing treatment strategies may involve considering the dynamics of tumor reduction.

    Related Experiment Videos